The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Anlotinib and irinotecan for advanced Ewing sarcoma after failure of standard therapy: A multicenter, two-cohort, single-arm, open label, phase Ib/II trial (NCT03416517).
 
Jie Xu
No Relationships to Disclose
 
Lu Xie
No Relationships to Disclose
 
Wei Guo
No Relationships to Disclose
 
Xiaodong Tang
No Relationships to Disclose
 
Rongli Yang
No Relationships to Disclose
 
Taiqiang Yan
No Relationships to Disclose
 
Kuisheng Liu
No Relationships to Disclose
 
Jin Gu
No Relationships to Disclose